Servicio de Nefrología, Fundación Valle del Lili, Carrera 98 No.18-49, 760032, Cali, Colombia.
Facultad de Ciencias de la Salud, Universidad Icesi, Calle 18 # 122-135, Cali, Colombia.
Sci Rep. 2024 Aug 5;14(1):18091. doi: 10.1038/s41598-024-67261-w.
Apparent resistant hypertension (aTRH) is a significant public health issue. Once low adherence to antihypertensive treatment has been ruled out and true resistant hypertension is diagnosed, aldosterone-direct-renin-ratio (ADRR) aids in the screening of an aldosterone-producing adenoma (APA) and primary aldosteronism (PA). Once PA and other secondary causes have been ruled out, the values of aldosterone and renin allow patients to be classified into phenotypes such as low renin hypertension (LRH), Liddle's-like (LLph), and primary hyperaldosteronism (PAph). These classifications could aid in the treatment decision-making process. However, optimal cut-off points for these classifications remain uncertain. This study aims to assess the prevalence of these phenotypes and the behavior of different cut-offs of the ADRR in an Afro-Colombian population with apparent resistant hypertension, as well to describe their sodium consumption. Afro-descendant individuals 18 years of age or older, diagnosed with resistant hypertension and attending to a primary care center in Colombia were recruited as volunteers. As part of the study, their plasma renin concentration (PRC) and plasma aldosterone concentration (PAC) were measured. The phenotypes were categorized into three groups based on multiple cut-off points from different authors: low renin and low aldosterone phenotype (LLph), low renin and high aldosterone phenotype (PAph), and high renin and high aldosterone phenotype, referred to as the renal phenotype (Rph). The prevalence of ADRR values exceeding the cut-off and phenotypes were calculated. A linear regression model was derived to assess the effect of sodium consumption with PAC, PRC and ADRR. A total of 88 patients with aTRH were included. Adherence to at least 3 antihypertensive medications was 62.5%. The median age was 56 years (IQR 48-60), 44% were female, and 20% had diabetes. The study found that the prevalence of ADRR values exceeding the cut-off ranged from 4.5 to 23%, while low-renin hypertension (LRH) varied from 15 to 74%, Rph was found in approximately 30 to 34% of patients, PAph in 30 to 51%, and the LLph in 15 to 41%, respectively, depending on the specific cut-off value by different authors. Notably, sodium consumption was associated with lower aldosterone (β - 0.15, 95% CI [- 0.27, - 0.03]) and renin concentrations (β - 0.75, 95% CI [- 1.5, - 0.02]), but ADRR showed no significant association with sodium consumption. There were no significant differences in prevalences between the groups taking < 3 vs ≥ 3 antihypertensive medications. Altered aldosterone-direct-renin-ratio, low renin hypertension, Liddle's-like, and primary hyperaldosteronism are prevalent phenotypes in patients within Afro-Colombian patients with apparent treatment-Resistant hypertension.
明显的抗高血压治疗抵抗(aTRH)是一个重大的公共卫生问题。一旦排除了抗高血压治疗的低依从性,并诊断出真正的抗高血压治疗抵抗,醛固酮-直接肾素比值(ADRR)有助于筛查产生醛固酮的腺瘤(APA)和原发性醛固酮增多症(PA)。一旦排除了 PA 和其他继发性原因,醛固酮和肾素的值可以将患者分为低肾素高血压(LRH)、Liddle 样(LLph)和原发性醛固酮增多症(PAph)等表型。这些分类可以帮助治疗决策过程。然而,这些分类的最佳截止值仍然不确定。本研究旨在评估在一个具有明显抗高血压治疗抵抗的 Afro-Colombian 人群中,这些表型的患病率以及不同 ADRR 截止值的行为,并描述他们的钠摄入量。年龄在 18 岁或以上、被诊断为抗高血压治疗抵抗并在哥伦比亚的一个初级保健中心就诊的 Afro-descendant 个体被招募为志愿者。作为研究的一部分,测量了他们的血浆肾素浓度(PRC)和血浆醛固酮浓度(PAC)。根据不同作者的多个截止值,将表型分为三组:低肾素和低醛固酮表型(LLph)、低肾素和高醛固酮表型(PAph)以及高肾素和高醛固酮表型,称为肾表型(Rph)。计算了 ADRR 值超过截止值和表型的患病率。得出了一个线性回归模型来评估钠摄入量与 PAC、PRC 和 ADRR 的关系。共纳入 88 例 aTRH 患者。至少服用 3 种降压药物的依从性为 62.5%。中位年龄为 56 岁(IQR 48-60),44%为女性,20%患有糖尿病。研究发现,ADRR 值超过截止值的患病率为 4.5%至 23%,而低肾素高血压(LRH)的患病率为 15%至 74%,Rph 约为 30%至 34%,PAph 为 30%至 51%,LLph 为 15%至 41%,具体取决于不同作者的特定截止值。值得注意的是,钠摄入量与较低的醛固酮(β-0.15,95%CI [-0.27,-0.03])和肾素浓度(β-0.75,95%CI [-1.5,-0.02])有关,但 ADRR 与钠摄入量无显著相关性。服用 <3 种与服用≥3 种降压药物的患者之间的患病率无显著差异。在 Afro-Colombian 患者中,醛固酮-直接肾素比值改变、低肾素高血压、Liddle 样和原发性醛固酮增多症是治疗抵抗性高血压患者中常见的表型。